Orchard-New-Logo-102419-v01-rgb.png
Orchard Therapeutics Bolsters R&D and Technical Operations Leadership with New Executive Appointments
September 09, 2021 07:00 ET | Orchard Therapeutics (Europe) Limited
Gene therapy experts Fulvio Mavilio, Ph.D., and Nicoletta Loggia, Ph.D., join as chief scientific officer and chief technical officer, respectively Neuroscience and rare disease leader Leslie...
builders_1st_logo_gc_jpg.jpg
Builders FirstSource Acquires Apollo Software Assets
September 09, 2021 07:00 ET | Builders FirstSource, Inc.
DALLAS, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Builders FirstSource, Inc. (NYSE: BLDR) (“Builders FirstSource” or the “Company”), today announced it acquired Apollo software assets from construction...
RWB-Wide-Logo.png
Red White & Bloom Florida Facility Ready for Production of Edibles
September 09, 2021 07:00 ET | Red White & Bloom Brands Inc.
TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) ("RWB" or the "Company"), a leading provider of cannabis brands in the US, has built-out a new...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma Presents Data at 2021 ESPEN Virtual Congress Demonstrating Dose-dependent Effects of Glepaglutide in Both Small and Large Intestines of Animal Models – in Contrast to Short-acting GLP-2
September 09, 2021 07:00 ET | Zealand Pharma
Company announcement – No. 59/ 2021 Zealand Pharma Presents Data at 2021 ESPEN Virtual Congress Demonstrating Dose-dependent Effects of Glepaglutide in Both Small and Large Intestines of Animal...
logo.jpg
Lassila & Tikanoja’s financial information and AGM in 2022
September 09, 2021 07:00 ET | Lassila & Tikanoja plc
Lassila & Tikanoja plc Stock exchange release 9 September 2021 2.00 pm Lassila & Tikanoja’s financial information and AGM in 2022 In the year 2022 Lassila & Tikanoja plc will disclose...
XPInc.jpg
XP Inc. Partners With Virgo in Order to Enhance Small and Medium Companies’ Access to Capital Markets
September 09, 2021 07:00 ET | XP Inc.
SÃO PAULO, Brazil, Sept. 09, 2021 (GLOBE NEWSWIRE) -- XP Inc. (Nasdaq: XP), a leading, technology-driven platform and a trusted provider of low-fee financial products and services in Brazil,...
bioxcel-therapeutics-local-250x100.jpg
BioXcel Therapeutics to Host Virtual R&D Day on September 23, 2021
September 09, 2021 07:00 ET | BioXcel Therapeutics
Live webcast, Revolutionizing Drug Discovery and Development Through AI, to be held from 12:00 PM ET – 2:00 PM ET NEW HAVEN, Conn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc....
2019 logo_150x35_jpg.jpg
Novan Announces Strategic Priorities and Outlines Key Milestones
September 09, 2021 07:00 ET | Novan, Inc.
– Company planning for three potential New Drug Application (NDA) filings in three years with the first submission expected in Q3 2022 for lead program SB206 in molluscum contagiosum – – Late-stage...
Inivata_CMYK_Logo.jpg
Inivata and collaborators to present data that further validate the application of its RaDaR™ MRD and InVisionFirst®-Lung assays at the ESMO Congress 2021
September 09, 2021 07:00 ET | Inivata
Inivata and collaborators to present data that further validate the application of its RaDaR™ MRD and InVisionFirst®-Lung assays at the ESMO Congress 2021 Research Triangle Park, NC, USA and...
20191022192841614.jpg
BeyondSpring Announces Three Poster Presentations About its Chemotherapy-Induced Neutropenia Prevention Program at the European Society for Medical Oncology 2021 Congress
September 09, 2021 07:00 ET | BeyondSpring, Inc.
Plinabulin in combination with G-CSF is undergoing regulatory review for potential approval in the U.S. and China for the prevention of CIN, with a U.S. PDUFA date of November 30, 2021. NEW YORK,...